A Canadian recall of an over-the-counter pain reliever affects a lot of 500-milligram Novo-Gesic Forte acetaminophen due to the potential presence of phenolic resin or epoxy, according to a news release issued by Health Canada. According to Health Canada and Newswire, the contaminant could potentially cause injury to the digestive system if ingested.
Details of the Teva Canada Acetaminophen Recall
Teva Canada Limited is recalling Lot No. 100083040 of Novo-Gesic Forte 500 mg acetaminophen, carrying an expiration date of Jan. 31, 2029, and Drug Identification Number (DIN) 00482323, according to regulatory notices from Health Canada and Newswire. The affected medication was originally distributed to pharmacies in 1,000-count bottles before being dispensed to individual patients in smaller quantities.
Health Canada has classified this public advisory as a Type I, national recall, meaning the depth of the recall extends down to the consumer level. Regulators are actively monitoring both the recall process and the preventative and corrective actions taken by the company, according to Newswire.
Did you know? Type I recalls represent situations where there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death. In this case, the foreign material poses a physical risk to the digestive tract.
Required Steps for Consumers and Patients
Patients who possess the affected medication should immediately stop using the product and return it to their local pharmacy for proper disposal and replacement, according to Health Canada. Because pharmacies often dispense pills from larger bulk containers into smaller vials, patients who are unsure whether their supply is part of the recalled lot must check directly with their dispensing pharmacist.
Anyone who has ingested the impacted tablets and experiences health worries should contact a healthcare practitioner immediately, according to public health advisories. Consumers can also report any product-related side effects or complaints directly to Health Canada.
How to Contact Teva Canada for Support
Customers seeking additional information regarding the recalled analgesic can reach out to Teva Canada Customer Care. According to company and agency contact details, inquiries can be made by calling the toll-free number at 1-800-268-4129 or by sending an email to customer.service@tevacanada.com.
The corporate headquarters for Teva Canada Limited is located at 30 Novopharm Court, Toronto, Ontario, M1B 2K9, as noted in Newswire filings. Media inquiries are handled by Health Canada through their media relations line at 613-957-2983 or via email at media@hc-sc.gc.ca, while public inquiries are directed to 1-866-225-0709.
Frequently Asked Questions
Which specific product and lot are affected by this recall?
The recall targets Novo-Gesic Forte 500 mg acetaminophen, Lot No. 100083040, with an expiry date of January 31, 2029, and DIN 00482323, according to Health Canada.
What is the safety concern associated with the recalled pills?
According to Health Canada, the tablets may contain phenolic resin or epoxy, which has the potential to cause injury to the digestive system if ingested.
What should I do if my prescription bottle does not show a lot number?
Because pharmacies frequently dispense medication in smaller quantities, patients should return to their local pharmacy to verify whether their specific supply belongs to the recalled lot, according to regulatory guidance.
Who should I contact if I experience side effects?
Patients with health concerns should contact a healthcare practitioner and report any adverse reactions or product complaints to Health Canada.
Stay Informed
Subscribe to our health and safety newsletter to receive prompt updates on product recalls, regulatory advisories, and consumer safety news.
Subscribe NowWorth a look